Biomarkers in renal cancer

Research output: Chapter in Book/Report/Conference proceedingChapter


Renal cell carcinoma (RCC) is the ninth most common malignancy worldwide and classically presents with a triad of flank pain, palpable abdominal mass, and gross hematuria. However, in clinical practice, the diagnosis of RCC is often discovered incidentally on imaging evaluation for nongenitourinary-related symptoms with the majority of cases not identified until advanced stages in the disease due to the asymptomatic presentation. There are numerous biomarkers that have emerged which may aid in the management of patients with RCC which will present in this chapter.

Original languageEnglish (US)
Title of host publicationKidney Biomarkers
Subtitle of host publicationClinical Aspects and Laboratory Determination
Number of pages13
ISBN (Electronic)9780128159231
StatePublished - Jan 1 2020


  • Biomarkers
  • Magnetic resonance imaging
  • Positron emission tomography
  • Renal cancer
  • Serum biomarkers
  • Urine biomarkers

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Biomarkers in renal cancer'. Together they form a unique fingerprint.

Cite this